izpis_h1_title_alt

Fine tuning of cholinesterase and glutathione-S-transferase activities by organoruthenium(II) complexes
ID Trobec, Tomaž (Author), ID Sepčić, Kristina (Author), ID Žužek, Monika C. (Author), ID Kladnik, Jerneja (Author), ID Podjed, Nina (Author), ID Cardoso Páscoa, Catarina (Author), ID Turel, Iztok (Author), ID Frangež, Robert (Author)

.pdfPDF - Presentation file, Download (751,83 KB)
MD5: EEC28853A00B56ECE9BC6CA24F8FBB6E
URLURL - Source URL, Visit https://www.mdpi.com/2227-9059/9/9/1243 This link opens in a new window

Abstract
Cholinesterases (ChEs) show increased activities in patients with Alzheimer’s disease, and remain one of the main therapeutic targets for treatment of this neurodegenerative disorder. A library of organoruthenium(II) complexes was prepared to investigate the influence of their structural elements on inhibition of ChEs, and on another pharmacologically important group of enzymes, glutathione S-transferases (GSTs). Two groups of organoruthenium(II) compounds were considered: (i) organoruthenium(II) complexes with p-cymene as an arene ligand, and (ii) organoruthenium(II) carbonyl complexes as CO-releasing molecules. Eight organoruthenium complexes were screened for inhibitory activities against ChEs and GSTs of human and animal origins. Some compounds inhibited all of these enzymes at low micromolar concentrations, while others selectively inhibited either ChEs or GSTs. This study demonstrates the importance of the different structural elements of organoruthenium complexes for their inhibitory activities against ChEs and GSTs, and also proposes some interesting compounds for further preclinical testing as ChE or GST inhibitory drugs.

Language:English
Keywords:cholinesterase, enzyme inhibition, glutathione S-transferase, organoruthenium complex, pyrithione, β-diketone, carbonyl, glutathione transferase
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:VF - Veterinary Faculty
BF - Biotechnical Faculty
FKKT - Faculty of Chemistry and Chemical Technology
Publication status:Published
Publication version:Version of Record
Year:2021
Number of pages:16 str.
Numbering:Vol. 9, iss. 9, art. 1243
PID:20.500.12556/RUL-136344 This link opens in a new window
UDC:636.09:612
ISSN on article:2227-9059
DOI:10.3390/biomedicines9091243 This link opens in a new window
COBISS.SI-ID:76757507 This link opens in a new window
Publication date in RUL:25.04.2022
Views:488
Downloads:88
Metadata:XML RDF-CHPDL DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Biomedicines
Shortened title:Biomedicines
Publisher:MDPI AG
ISSN:2227-9059
COBISS.SI-ID:523006745 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:16.09.2021

Projects

Funder:ARRS - Slovenian Research Agency
Project number:P4-0053
Name:Endokrini, imunski in encimski odzivi pri zdravih in bolnih živalih

Funder:ARRS - Slovenian Research Agency
Project number:P1-0207
Name:Toksini in biomembrane

Funder:ARRS - Slovenian Research Agency
Project number:P1-0175
Name:Napredna anorganska kemija

Funder:ARRS - Slovenian Research Agency
Funding programme:Young Researchers

Funder:EC - European Commission
Funding programme:Erasmus

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back